IFM Investors’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.02M | Buy |
97,633
+8,076
| +9% | +$760K | 0.05% | 332 |
|
|
2026
Q1 | $10.6M | Buy |
89,557
+2,643
| +3% | +$327K | 0.09% | 216 |
|
|
2025
Q4 | $10.9M | Buy |
86,914
+630
| +0.7% | +$82.2K | 0.09% | 194 |
|
|
2025
Q3 | $12.4M | Sell |
86,284
-530
| -0.6% | -$80.1K | 0.11% | 165 |
|
|
2025
Q2 | $13.5M | Buy |
86,814
+2,603
| +3% | +$413K | 0.13% | 156 |
|
|
2025
Q1 | $13.9M | Hold |
84,211
| – | – | 0.15% | 127 |
|
|
2024
Q4 | $13.7M | Sell |
84,211
-8,570
| -9% | -$1.53M | 0.14% | 138 |
|
|
2024
Q3 | $18.1M | Buy |
92,781
+35
| +0% | +$6.45K | 0.17% | 110 |
|
|
2024
Q2 | $16.1M | Buy |
92,746
+631
| +0.7% | +$105K | 0.16% | 113 |
|
|
2024
Q1 | $15.6M | Sell |
92,115
-722
| -0.8% | -$135K | 0.17% | 110 |
|
|
2023
Q4 | $18.3M | Sell |
92,837
-1,658
| -2% | -$294K | 0.22% | 92 |
|
|
2023
Q3 | $16.4M | Buy |
94,495
+3,975
| +4% | +$722K | 0.22% | 92 |
|
|
2023
Q2 | $15.6M | Buy |
90,520
+3,844
| +4% | +$665K | 0.2% | 94 |
|
|
2023
Q1 | $14.4M | Buy |
86,676
+1,732
| +2% | +$284K | 0.22% | 92 |
|
|
2022
Q4 | $12.4M | Buy |
84,944
+3,225
| +4% | +$477K | 0.21% | 102 |
|
|
2022
Q3 | $12.1M | Buy |
81,719
+1,651
| +2% | +$276K | 0.22% | 95 |
|
|
2022
Q2 | $13.8M | Buy |
80,068
+6,422
| +9% | +$1.11M | 0.24% | 85 |
|
|
2022
Q1 | $13.9M | Buy |
73,646
+10,364
| +16% | +$2.05M | 0.22% | 90 |
|
|
2021
Q4 | $15.4M | Sell |
63,282
-861
| -1% | -$189K | 0.28% | 72 |
|
|
2021
Q3 | $12.5M | Buy |
64,143
+2,451
| +4% | +$495K | 0.26% | 78 |
|
|
2021
Q2 | $11.5M | Buy |
61,692
+10,621
| +21% | +$1.84M | 0.24% | 90 |
|
|
2021
Q1 | $8.04M | Buy |
51,071
+5,105
| +11% | +$809K | 0.22% | 96 |
|
|
2020
Q4 | $7.61M | Buy |
45,966
+6,829
| +17% | +$1.11M | 0.24% | 87 |
|
|
2020
Q3 | $6.47M | Buy |
39,137
+4,100
| +12% | +$630K | 0.27% | 73 |
|
|
2020
Q2 | $4.8M | Sell |
35,037
-11,985
| -25% | -$1.56M | 0.25% | 82 |
|
|
2020
Q1 | $5.49M | Sell |
47,022
-1,789
| -4% | -$236K | 0.25% | 94 |
|
|
2019
Q4 | $6.46M | Sell |
48,811
-2,336
| -5% | -$290K | 0.23% | 95 |
|
|
2019
Q3 | $6.37M | Buy |
51,147
+17,178
| +51% | +$2.07M | 0.24% | 92 |
|
|
2019
Q2 | $3.85M | Buy |
33,969
+2,036
| +6% | +$213K | 0.22% | 97 |
|
|
2019
Q1 | $3.21M | Buy |
31,933
+4,085
| +15% | +$371K | 0.21% | 107 |
|
|
2018
Q4 | $2.38M | Buy |
27,848
+2,516
| +10% | +$227K | 0.19% | 116 |
|
|
2018
Q3 | $2.32M | Buy |
25,332
+3,484
| +16% | +$309K | 0.18% | 127 |
|
|
2018
Q2 | $1.86M | Buy |
21,848
+6,652
| +44% | +$562K | 0.18% | 131 |
|
|
2018
Q1 | $1.27M | Buy |
15,196
+1,437
| +10% | +$113K | 0.18% | 131 |
|
|
2017
Q4 | $991K | Sell |
13,759
-70
| -0.5% | -$4.81K | 0.16% | 150 |
|
|
2017
Q3 | $882K | Buy |
13,829
+466
| +3% | +$29.2K | 0.15% | 160 |
|
|
2017
Q2 | $834K | Buy |
13,363
+3,892
| +41% | +$230K | 0.15% | 160 |
|
|
2017
Q1 | $505K | Buy |
9,471
+3,462
| +58% | +$187K | 0.13% | 198 |
|
|
2016
Q4 | $322K | Buy |
+6,009
| New | +$305K | 0.15% | 176 |
|
Other funds holding ZTS
MBI
SI
MIHAS
FFM
CIM
SIM
DLA
IFM Investors's ZTS Position: Q2 2026 in Review
IFM Investors increased its Zoetis (ZTS) stake by 9% in Q2 2026, buying an estimated $760K and bringing the position to 97,633 shares worth $7.02M. The position accounts for 0.05% of the portfolio, ranked #332.
IFM Investors first reported a position in ZTS in Q4 2016 and has held it in 39 quarters since. The position peaked at $18.3M in Q4 2023. 271 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- IFM Investors held 97,633 shares of Zoetis worth $7.02M as of Q2 2026.
- IFM Investors bought 8,076 Zoetis shares in Q2 2026, an estimated $760K.
- Zoetis made up 0.05% of IFM Investors's portfolio in Q2 2026, its #332 holding.
- IFM Investors first reported a position in Zoetis in Q4 2016 and has held it in 39 quarters since.
- IFM Investors's Zoetis position peaked at $18.3M in Q4 2023.
- 271 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.